| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | gamma-catenin binding | 3.99e-04 | 12 | 50 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 3.99e-04 | 12 | 50 | 2 | GO:0001851 | |
| GeneOntologyBiologicalProcess | adaptive immune response | EPHB2 CFH LIG4 IGLV2-18 IGLV2-14 IGLV2-11 BTN3A3 IGLV2-8 SUSD4 IL18 TRA TRAV38-2DV8 IGLV6-57 BTN3A2 BTN3A1 SVEP1 CFHR4 | 1.10e-11 | 838 | 52 | 17 | GO:0002250 |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | CFH LIG4 IGLV2-14 BTN3A3 SUSD4 IL18 ABR TRA BTN3A2 MILR1 SVEP1 CFHR4 | 1.50e-08 | 576 | 52 | 12 | GO:0002443 |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | EPHB2 CFH LIG4 IGLV2-14 BTN3A3 SUSD4 IL18 TRA BTN3A2 SVEP1 CFHR4 | 1.67e-08 | 462 | 52 | 11 | GO:0002460 |
| GeneOntologyBiologicalProcess | immune effector process | EPHB2 CFH LIG4 IGLV2-14 BTN3A3 SUSD4 IL18 ABR TRA MUC19 BTN3A2 MILR1 SVEP1 CFHR4 | 1.72e-08 | 859 | 52 | 14 | GO:0002252 |
| GeneOntologyBiologicalProcess | immunoglobulin production | EPHB2 LIG4 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 TRAV38-2DV8 IGLV6-57 | 1.49e-07 | 241 | 52 | 8 | GO:0002377 |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.51e-07 | 449 | 52 | 10 | GO:0002449 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, alternative pathway | 5.25e-07 | 7 | 52 | 3 | GO:0030451 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 6.04e-07 | 27 | 52 | 4 | GO:0030449 | |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | EPHB2 LIG4 IGLV2-18 IGLV2-14 IGLV2-11 IGLV2-8 IL18 TRAV38-2DV8 IGLV6-57 | 6.64e-07 | 403 | 52 | 9 | GO:0002440 |
| GeneOntologyBiologicalProcess | regulation of immune response | EPHB2 CFH BTN3A3 SUSD4 IL18 ABR TLR5 IGSF1 BTN3A2 BTN3A1 SVEP1 CFHR4 | 1.23e-05 | 1085 | 52 | 12 | GO:0050776 |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 1.42e-05 | 19 | 52 | 3 | GO:0006957 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 1.58e-05 | 60 | 52 | 4 | GO:0002920 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 2.70e-05 | 235 | 52 | 6 | GO:0016064 | |
| GeneOntologyBiologicalProcess | complement activation | 2.91e-05 | 70 | 52 | 4 | GO:0006956 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 3.33e-05 | 244 | 52 | 6 | GO:0019724 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | EPHB2 CFH LGMN SUSD4 IL18 ABR NRXN1 SIGIRR TLR5 MUC19 EPHA4 CFHR4 | 8.22e-05 | 1316 | 52 | 12 | GO:0032101 |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 9.29e-05 | 6 | 52 | 2 | GO:0001905 | |
| GeneOntologyBiologicalProcess | neutrophil homeostasis | 9.34e-05 | 35 | 52 | 3 | GO:0001780 | |
| GeneOntologyBiologicalProcess | activation of immune response | 1.54e-04 | 623 | 52 | 8 | GO:0002253 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 1.73e-04 | 8 | 52 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | EPHB2 CFH LGMN BTN3A3 SUSD4 IL18 TLR5 BTN3A2 BTN3A1 SVEP1 CFHR4 | 2.22e-04 | 1242 | 52 | 11 | GO:0002684 |
| GeneOntologyBiologicalProcess | monocyte aggregation | 2.22e-04 | 9 | 52 | 2 | GO:0070487 | |
| GeneOntologyBiologicalProcess | immune complex clearance | 2.22e-04 | 9 | 52 | 2 | GO:0002434 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 2.35e-04 | 845 | 52 | 9 | GO:0050778 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 2.37e-04 | 497 | 52 | 7 | GO:0002697 | |
| GeneOntologyBiologicalProcess | cellular response to amyloid-beta | 2.57e-04 | 49 | 52 | 3 | GO:1904646 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 2.77e-04 | 10 | 52 | 2 | GO:0030450 | |
| GeneOntologyBiologicalProcess | retinal pigment epithelium development | 2.77e-04 | 10 | 52 | 2 | GO:0003406 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 3.38e-04 | 11 | 52 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 3.81e-04 | 246 | 52 | 5 | GO:0045216 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 4.05e-04 | 12 | 52 | 2 | GO:0002924 | |
| GeneOntologyBiologicalProcess | response to bacterium | 4.26e-04 | 916 | 52 | 9 | GO:0009617 | |
| GeneOntologyBiologicalProcess | cell activation | 4.71e-04 | 1356 | 52 | 11 | GO:0001775 | |
| GeneOntologyBiologicalProcess | regulation of complement-dependent cytotoxicity | 4.78e-04 | 13 | 52 | 2 | GO:1903659 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 4.91e-04 | 61 | 52 | 3 | GO:1904645 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 5.56e-04 | 14 | 52 | 2 | GO:0045916 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 6.46e-04 | 67 | 52 | 3 | GO:1900271 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 7.31e-04 | 16 | 52 | 2 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 7.31e-04 | 16 | 52 | 2 | GO:0002890 | |
| GeneOntologyBiologicalProcess | complement-dependent cytotoxicity | 7.31e-04 | 16 | 52 | 2 | GO:0097278 | |
| GeneOntologyBiologicalProcess | T cell mediated immunity | 7.57e-04 | 163 | 52 | 4 | GO:0002456 | |
| GeneOntologyBiologicalProcess | mechanosensory behavior | 8.28e-04 | 17 | 52 | 2 | GO:0007638 | |
| GeneOntologyBiologicalProcess | retinal rod cell development | 8.28e-04 | 17 | 52 | 2 | GO:0046548 | |
| GeneOntologyBiologicalProcess | regulation of NMDA receptor activity | 9.29e-04 | 18 | 52 | 2 | GO:2000310 | |
| GeneOntologyBiologicalProcess | leukocyte aggregation | 1.04e-03 | 19 | 52 | 2 | GO:0070486 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 1.04e-03 | 19 | 52 | 2 | GO:0002921 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 5.71e-05 | 166 | 52 | 5 | GO:0019814 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.68e-04 | 8 | 52 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.91e-04 | 45 | 52 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | other organism part | 2.16e-04 | 9 | 52 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 4.65e-04 | 13 | 52 | 2 | GO:0030877 | |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 1.12e-03 | 20 | 52 | 2 | GO:1905370 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 1.36e-03 | 22 | 52 | 2 | GO:1905286 | |
| GeneOntologyCellularComponent | cell surface | 1.53e-03 | 1111 | 52 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.76e-03 | 519 | 52 | 6 | GO:0009897 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.53e-03 | 109 | 52 | 3 | GO:0005796 | |
| HumanPheno | Fundic gland polyposis | 6.01e-06 | 2 | 13 | 2 | HP:0033769 | |
| MousePheno | abnormal complement protein level | 1.30e-06 | 9 | 36 | 3 | MP:0011566 | |
| MousePheno | abnormal creatine level | 1.30e-06 | 9 | 36 | 3 | MP:0010060 | |
| MousePheno | artery occlusion | 6.45e-06 | 2 | 36 | 2 | MP:0006134 | |
| MousePheno | abnormal hepatic portal vein thrombosis | 6.45e-06 | 2 | 36 | 2 | MP:0031159 | |
| MousePheno | white pupil | 6.45e-06 | 2 | 36 | 2 | MP:0006242 | |
| MousePheno | decreased serum complement activity | 6.45e-06 | 2 | 36 | 2 | MP:0012553 | |
| MousePheno | decreased complement C5 level | 6.45e-06 | 2 | 36 | 2 | MP:0012609 | |
| MousePheno | abnormal complement C5 level | 6.45e-06 | 2 | 36 | 2 | MP:0012608 | |
| MousePheno | abnormal kidney venous thrombosis | 1.93e-05 | 3 | 36 | 2 | MP:0031161 | |
| MousePheno | increased susceptilbility to retina ischemic injury | 1.93e-05 | 3 | 36 | 2 | MP:0012049 | |
| MousePheno | increased susceptibility to type III hypersensitivity reaction | 3.86e-05 | 4 | 36 | 2 | MP:0005615 | |
| MousePheno | mesangial cell interposition | 3.86e-05 | 4 | 36 | 2 | MP:0011512 | |
| MousePheno | abnormal brain thrombosis | 3.86e-05 | 4 | 36 | 2 | MP:0031168 | |
| MousePheno | abnormal response to retina ischemic injury | 3.86e-05 | 4 | 36 | 2 | MP:0012048 | |
| MousePheno | decreased circulating complement protein level | 3.86e-05 | 4 | 36 | 2 | MP:0020216 | |
| MousePheno | increased creatine level | 3.86e-05 | 4 | 36 | 2 | MP:0010061 | |
| MousePheno | abnormal complement pathway | 3.92e-05 | 26 | 36 | 3 | MP:0002471 | |
| MousePheno | abnormal venous thrombosis | 6.42e-05 | 5 | 36 | 2 | MP:0031158 | |
| MousePheno | abnormal lung thrombosis | 6.42e-05 | 5 | 36 | 2 | MP:0031167 | |
| MousePheno | abnormal circulating complement protein level | 9.61e-05 | 6 | 36 | 2 | MP:0010215 | |
| MousePheno | abnormal intestine physiology | 9.96e-05 | 297 | 36 | 6 | MP:0010155 | |
| MousePheno | intestinal inflammation | 1.33e-04 | 195 | 36 | 5 | MP:0001858 | |
| MousePheno | abnormal glomerular capillary thrombosis | 1.34e-04 | 7 | 36 | 2 | MP:0011508 | |
| MousePheno | brain ischemia | 1.79e-04 | 8 | 36 | 2 | MP:0006080 | |
| MousePheno | increased large intestine adenocarcinoma incidence | 1.79e-04 | 8 | 36 | 2 | MP:0009310 | |
| MousePheno | abnormal adaptive immunity | MYCL CFH LGMN LIG4 IGLV2-14 SUSD4 IL18 SIGIRR TLR5 OCA2 MILR1 CFHR4 | 2.24e-04 | 1490 | 36 | 12 | MP:0002420 |
| MousePheno | abnormal type III hypersensitivity reaction | 2.86e-04 | 10 | 36 | 2 | MP:0002533 | |
| MousePheno | abnormal kidney thrombosis | 2.86e-04 | 10 | 36 | 2 | MP:0011507 | |
| MousePheno | abnormal anterior commissure pars posterior morphology | 2.86e-04 | 10 | 36 | 2 | MP:0010860 | |
| MousePheno | increased susceptibility to induced colitis | 3.15e-04 | 128 | 36 | 4 | MP:0008537 | |
| MousePheno | abnormal visual acuity | 4.94e-04 | 13 | 36 | 2 | MP:0011832 | |
| MousePheno | decreased visual acuity | 4.94e-04 | 13 | 36 | 2 | MP:0006149 | |
| MousePheno | increased total fat pad weight | 4.94e-04 | 13 | 36 | 2 | MP:0008908 | |
| MousePheno | albuminuria | 5.60e-04 | 63 | 36 | 3 | MP:0002871 | |
| MousePheno | abnormal Bruch membrane morphology | 5.75e-04 | 14 | 36 | 2 | MP:0005239 | |
| MousePheno | retina detachment | 6.63e-04 | 15 | 36 | 2 | MP:0003099 | |
| MousePheno | colitis | 7.15e-04 | 159 | 36 | 4 | MP:0002816 | |
| MousePheno | abnormal digestive system physiology | 7.22e-04 | 599 | 36 | 7 | MP:0001663 | |
| MousePheno | abnormal parental behavior | 7.32e-04 | 160 | 36 | 4 | MP:0002068 | |
| MousePheno | abnormal susceptibility to induced colitis | 7.49e-04 | 161 | 36 | 4 | MP:0013296 | |
| MousePheno | increased acute inflammation | 8.03e-04 | 164 | 36 | 4 | MP:0005088 | |
| MousePheno | amyloid beta deposits | 8.56e-04 | 17 | 36 | 2 | MP:0003329 | |
| MousePheno | cardia bifida | 8.56e-04 | 17 | 36 | 2 | MP:0004187 | |
| MousePheno | large intestinal inflammation | 1.00e-03 | 174 | 36 | 4 | MP:0003304 | |
| MousePheno | decreased interleukin-12b secretion | 1.07e-03 | 19 | 36 | 2 | MP:0008670 | |
| MousePheno | hematuria | 1.07e-03 | 19 | 36 | 2 | MP:0005161 | |
| MousePheno | reticulocytosis | 1.12e-03 | 80 | 36 | 3 | MP:0002640 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 1.31e-03 | 21 | 36 | 2 | MP:0011453 | |
| MousePheno | abnormal innate immunity | 1.36e-03 | 667 | 36 | 7 | MP:0002419 | |
| MousePheno | increased intestinal adenocarcinoma incidence | 1.44e-03 | 22 | 36 | 2 | MP:0002957 | |
| MousePheno | abnormal gut flora balance | 1.44e-03 | 22 | 36 | 2 | MP:0010377 | |
| MousePheno | abnormal retina rod bipolar cell morphology | 1.58e-03 | 23 | 36 | 2 | MP:0006074 | |
| MousePheno | abnormal reticulocyte cell number | 1.63e-03 | 91 | 36 | 3 | MP:0011913 | |
| Domain | Ephrin_rec_like | 3.58e-07 | 25 | 45 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.58e-07 | 25 | 45 | 4 | IPR011641 | |
| Domain | Ig-like_fold | EPHB2 BTN3A3 TRA SIGIRR IGSF1 BTN3A2 BTN3A1 MILR1 EPHA4 TMEM81 | 5.37e-06 | 706 | 45 | 10 | IPR013783 |
| Domain | Sushi | 7.31e-06 | 52 | 45 | 4 | PF00084 | |
| Domain | CCP | 8.51e-06 | 54 | 45 | 4 | SM00032 | |
| Domain | SUSHI | 9.85e-06 | 56 | 45 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.06e-05 | 57 | 45 | 4 | IPR000436 | |
| Domain | - | 2.39e-05 | 663 | 45 | 9 | 2.60.40.10 | |
| Domain | IG_LIKE | 1.59e-04 | 491 | 45 | 7 | PS50835 | |
| Domain | Ig-like_dom | 1.84e-04 | 503 | 45 | 7 | IPR007110 | |
| Domain | Ephrin_rec_like | 3.08e-04 | 11 | 45 | 2 | PF07699 | |
| Domain | TIL | 3.69e-04 | 12 | 45 | 2 | PF01826 | |
| Domain | C8 | 3.69e-04 | 12 | 45 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 4.35e-04 | 13 | 45 | 2 | IPR014853 | |
| Domain | C8 | 4.35e-04 | 13 | 45 | 2 | SM00832 | |
| Domain | IG | 4.90e-04 | 421 | 45 | 6 | SM00409 | |
| Domain | Ig_sub | 4.90e-04 | 421 | 45 | 6 | IPR003599 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 5.07e-04 | 14 | 45 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 5.07e-04 | 14 | 45 | 2 | PS00790 | |
| Domain | Eph_TM | 5.07e-04 | 14 | 45 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 5.07e-04 | 14 | 45 | 2 | IPR001426 | |
| Domain | EPH_lbd | 5.07e-04 | 14 | 45 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 5.07e-04 | 14 | 45 | 2 | PF01404 | |
| Domain | TIL_dom | 5.07e-04 | 14 | 45 | 2 | IPR002919 | |
| Domain | EphA2_TM | 5.07e-04 | 14 | 45 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 5.07e-04 | 14 | 45 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 5.07e-04 | 14 | 45 | 2 | IPR001090 | |
| Domain | EPH_LBD | 5.07e-04 | 14 | 45 | 2 | PS51550 | |
| Domain | VWD | 6.67e-04 | 16 | 45 | 2 | SM00216 | |
| Domain | VWF_type-D | 6.67e-04 | 16 | 45 | 2 | IPR001846 | |
| Domain | VWFD | 6.67e-04 | 16 | 45 | 2 | PS51233 | |
| Domain | VWD | 6.67e-04 | 16 | 45 | 2 | PF00094 | |
| Domain | - | 7.23e-04 | 73 | 45 | 3 | 2.60.120.260 | |
| Domain | IGv | 7.82e-04 | 75 | 45 | 3 | SM00406 | |
| Domain | CTCK_1 | 8.47e-04 | 18 | 45 | 2 | PS01185 | |
| Domain | VWC_out | 9.46e-04 | 19 | 45 | 2 | SM00215 | |
| Domain | TIR | 1.16e-03 | 21 | 45 | 2 | SM00255 | |
| Domain | TIR | 1.27e-03 | 22 | 45 | 2 | PF01582 | |
| Domain | CT | 1.27e-03 | 22 | 45 | 2 | SM00041 | |
| Domain | - | 1.39e-03 | 23 | 45 | 2 | 3.40.50.10140 | |
| Domain | Galactose-bd-like | 1.50e-03 | 94 | 45 | 3 | IPR008979 | |
| Domain | TIR | 1.51e-03 | 24 | 45 | 2 | PS50104 | |
| Domain | Cys_knot_C | 1.64e-03 | 25 | 45 | 2 | IPR006207 | |
| Domain | CTCK_2 | 1.64e-03 | 25 | 45 | 2 | PS01225 | |
| Domain | TIR_dom | 1.64e-03 | 25 | 45 | 2 | IPR000157 | |
| Domain | PROTEIN_KINASE_TYR | 1.65e-03 | 97 | 45 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.65e-03 | 97 | 45 | 3 | IPR008266 | |
| Domain | ConA-like_dom | 1.88e-03 | 219 | 45 | 4 | IPR013320 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.12e-03 | 106 | 45 | 3 | IPR000152 | |
| Domain | EGF | 2.43e-03 | 235 | 45 | 4 | SM00181 | |
| Domain | EGF-like_dom | 2.99e-03 | 249 | 45 | 4 | IPR000742 | |
| Domain | EGF | 3.46e-03 | 126 | 45 | 3 | PF00008 | |
| Domain | EGF_2 | 3.74e-03 | 265 | 45 | 4 | PS01186 | |
| Domain | VWC | 3.78e-03 | 38 | 45 | 2 | SM00214 | |
| Domain | VWFC_2 | 3.78e-03 | 38 | 45 | 2 | PS50184 | |
| Domain | PRY | 4.60e-03 | 42 | 45 | 2 | PF13765 | |
| Domain | VWF_dom | 4.60e-03 | 42 | 45 | 2 | IPR001007 | |
| Domain | PRY | 5.97e-03 | 48 | 45 | 2 | SM00589 | |
| Domain | PRY | 5.97e-03 | 48 | 45 | 2 | IPR006574 | |
| Domain | Growth_fac_rcpt_ | 6.27e-03 | 156 | 45 | 3 | IPR009030 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 6.77e-07 | 115 | 39 | 6 | M19752 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 4.23e-06 | 12 | 39 | 3 | M27738 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.99e-06 | 98 | 39 | 5 | M27152 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 2.33e-05 | 61 | 39 | 4 | M27581 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 3.80e-05 | 69 | 39 | 4 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 3.80e-05 | 69 | 39 | 4 | M27150 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 4.25e-05 | 71 | 39 | 4 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 4.25e-05 | 71 | 39 | 4 | M27203 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 6.80e-05 | 80 | 39 | 4 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 7.49e-05 | 82 | 39 | 4 | M27110 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 9.02e-05 | 86 | 39 | 4 | M27206 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 9.02e-05 | 86 | 39 | 4 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 9.44e-05 | 87 | 39 | 4 | M27205 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 1.11e-04 | 6 | 39 | 2 | M47880 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.33e-04 | 95 | 39 | 4 | M29842 | |
| Pathway | REACTOME_PARASITE_INFECTION | 2.87e-04 | 116 | 39 | 4 | M29843 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 3.24e-04 | 219 | 39 | 5 | M29836 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | LGMN IGLV2-14 IGLV2-11 BTN3A3 IGLV2-8 KLHL13 IGLV6-57 BTN3A2 BTN3A1 | 3.42e-04 | 828 | 39 | 9 | M1058 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 4.84e-04 | 12 | 39 | 2 | M47410 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 4.96e-04 | 134 | 39 | 4 | M29840 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 5.25e-04 | 136 | 39 | 4 | M27207 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 6.34e-04 | 143 | 39 | 4 | M27107 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | CFH LGMN IGLV2-14 IGLV2-11 IGLV2-8 DSG1 SIGIRR TLR5 IGLV6-57 CFHR4 | 7.67e-04 | 1128 | 39 | 10 | M1036 |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 8.37e-04 | 154 | 39 | 4 | M39007 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.11e-03 | 166 | 39 | 4 | M608 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 1.11e-03 | 18 | 39 | 2 | M31 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.52e-03 | 21 | 39 | 2 | MM15706 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.60e-03 | 84 | 39 | 3 | MM14653 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 1.68e-03 | 186 | 39 | 4 | M27175 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.82e-03 | 190 | 39 | 4 | M8240 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.96e-03 | 194 | 39 | 4 | M16312 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 2.32e-03 | 26 | 39 | 2 | M39407 | |
| Pubmed | 3.34e-09 | 3 | 53 | 3 | 22767497 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 1.23e-08 | 49 | 53 | 5 | 8951372 | |
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 1.34e-08 | 4 | 53 | 3 | 39142074 | |
| Pubmed | 3.33e-08 | 5 | 53 | 3 | 29339503 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 1.16e-07 | 7 | 53 | 3 | 11170752 | |
| Pubmed | IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. | 5.47e-07 | 11 | 53 | 3 | 23075849 | |
| Pubmed | 5.67e-07 | 43 | 53 | 4 | 1249422 | ||
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | 7.02e-07 | 109 | 53 | 5 | 9074928 | |
| Pubmed | 8.16e-07 | 47 | 53 | 4 | 814163 | ||
| Pubmed | 8.90e-07 | 48 | 53 | 4 | 11955599 | ||
| Pubmed | 1.20e-06 | 14 | 53 | 3 | 7894156 | ||
| Pubmed | Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production. | 2.28e-06 | 2 | 53 | 2 | 31354740 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 28139755 | ||
| Pubmed | Absence of complement factor H reduces physical performance in C57BL6 mice. | 2.28e-06 | 2 | 53 | 2 | 32962822 | |
| Pubmed | Dietary induction of colonic tumors in a mouse model of sporadic colon cancer. | 2.28e-06 | 2 | 53 | 2 | 18829535 | |
| Pubmed | Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. | 2.28e-06 | 2 | 53 | 2 | 20538999 | |
| Pubmed | Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2. | 2.28e-06 | 2 | 53 | 2 | 4992636 | |
| Pubmed | Retinal changes precede visual dysfunction in the complement factor H knockout mouse. | 2.28e-06 | 2 | 53 | 2 | 23844226 | |
| Pubmed | Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. | 2.28e-06 | 2 | 53 | 2 | 21918970 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22846996 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 8615824 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30642982 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26374608 | ||
| Pubmed | Pre-synaptic and post-synaptic localization of EphA4 and EphB2 in adult mouse forebrain. | 2.28e-06 | 2 | 53 | 2 | 18410519 | |
| Pubmed | A gene locus concerned with an antigenic serum substance in Mus musculus. | 2.28e-06 | 2 | 53 | 2 | 4955525 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 2533512 | ||
| Pubmed | Complement factor H: spatial and temporal expression and localization in the eye. | 2.28e-06 | 2 | 53 | 2 | 16936129 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33558624 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29398083 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 37940659 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19620346 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32340123 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30705315 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18794118 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20416302 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33859044 | ||
| Pubmed | Regulation of age-related macular degeneration-like pathology by complement factor H. | 2.28e-06 | 2 | 53 | 2 | 25991857 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11572780 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25933092 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18695888 | ||
| Pubmed | Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. | 2.28e-06 | 2 | 53 | 2 | 21982234 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29288229 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33708358 | ||
| Pubmed | Serological survey of complement factor H in common laboratory and wild mice: a new third allotype. | 2.28e-06 | 2 | 53 | 2 | 2522412 | |
| Pubmed | Absence of complement factor H alters bone architecture and dynamics. | 2.28e-06 | 2 | 53 | 2 | 30107932 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19542617 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 34054871 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17562771 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27397653 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29392311 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22174452 | ||
| Pubmed | Loss of Complement Factor H in Plasma Increases Endothelial Cell Migration. | 2.28e-06 | 2 | 53 | 2 | 28819420 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22875704 | ||
| Pubmed | Local complement factor H protects kidney endothelial cell structure and function. | 2.28e-06 | 2 | 53 | 2 | 34139209 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23799019 | ||
| Pubmed | Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis. | 2.28e-06 | 2 | 53 | 2 | 32849636 | |
| Pubmed | Complement factor h is critical in the maintenance of retinal perfusion. | 2.28e-06 | 2 | 53 | 2 | 19541934 | |
| Pubmed | Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. | 2.28e-06 | 2 | 53 | 2 | 17921253 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24664701 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26149919 | ||
| Pubmed | The roles of Eph receptors in contextual fear conditioning memory formation. | 2.28e-06 | 2 | 53 | 2 | 26165136 | |
| Pubmed | Murine protein H is comprised of 20 repeating units, 61 amino acids in length. | 2.28e-06 | 2 | 53 | 2 | 2940596 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32165615 | ||
| Pubmed | Death by color: differential cone loss in the aging mouse retina. | 2.28e-06 | 2 | 53 | 2 | 24929970 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24370827 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21113407 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19232344 | ||
| Pubmed | Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis. | 2.28e-06 | 2 | 53 | 2 | 23436934 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23469078 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25921262 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15574507 | ||
| Pubmed | The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model. | 2.28e-06 | 2 | 53 | 2 | 19737405 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23133374 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11809809 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30808757 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21544060 | ||
| Pubmed | Role of ocular complement factor H in a murine model of choroidal neovascularization. | 2.28e-06 | 2 | 53 | 2 | 20813971 | |
| Pubmed | Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding. | 2.28e-06 | 2 | 53 | 2 | 1486806 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26030099 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17517971 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20445496 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31133737 | ||
| Pubmed | High-density lipoproteins are a potential therapeutic target for age-related macular degeneration. | 2.28e-06 | 2 | 53 | 2 | 32737203 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 16597679 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 37471073 | ||
| Pubmed | Complement Factor H Serum Levels Determine Resistance to Pneumococcal Invasive Disease. | 2.28e-06 | 2 | 53 | 2 | 26802141 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25447048 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 2972715 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 34775843 | ||
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 2.68e-06 | 18 | 53 | 3 | 9149941 | |
| Pubmed | 5.79e-06 | 23 | 53 | 3 | 19571816 | ||
| Pubmed | Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. | 6.61e-06 | 24 | 53 | 3 | 11739537 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 12091909 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 36499472 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 17420242 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 29070671 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 30972735 | ||
| Pubmed | Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease. | 6.83e-06 | 3 | 53 | 2 | 30025090 | |
| Pubmed | Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. | 6.83e-06 | 3 | 53 | 2 | 16023208 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 21302086 | ||
| Interaction | BTN3A1 interactions | 2.31e-05 | 23 | 49 | 3 | int:BTN3A1 | |
| Interaction | BTN3A3 interactions | 3.38e-05 | 26 | 49 | 3 | int:BTN3A3 | |
| Interaction | BTN3A2 interactions | 3.38e-05 | 26 | 49 | 3 | int:BTN3A2 | |
| Cytoband | 22q11.2 | 2.91e-07 | 120 | 53 | 5 | 22q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 8.91e-06 | 419 | 53 | 6 | chr22q11 | |
| Cytoband | 1q32 | 1.49e-03 | 49 | 53 | 2 | 1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 3.44e-03 | 75 | 53 | 2 | chr1q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q41 | 5.23e-03 | 93 | 53 | 2 | chr1q41 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 1.90e-06 | 89 | 42 | 5 | 353 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 5.20e-06 | 15 | 42 | 3 | 458 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.09e-06 | 57 | 42 | 4 | 1179 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 4.71e-04 | 14 | 42 | 2 | 1095 | |
| GeneFamily | Immunoglobulin like domain containing | 1.03e-03 | 193 | 42 | 4 | 594 | |
| GeneFamily | CD molecules|Mucins | 1.08e-03 | 21 | 42 | 2 | 648 | |
| GeneFamily | Complement system|Sushi domain containing | 3.16e-03 | 36 | 42 | 2 | 492 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 6.38e-03 | 163 | 42 | 3 | 590 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 4.11e-06 | 485 | 51 | 8 | M8513 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 3.67e-05 | 193 | 51 | 5 | M6813 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 3.76e-05 | 194 | 51 | 5 | M7306 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 3.95e-05 | 196 | 51 | 5 | MM667 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN | 4.24e-05 | 199 | 51 | 5 | M6843 | |
| Coexpression | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 | 4.74e-05 | 36 | 51 | 3 | M347 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 5.06e-05 | 104 | 51 | 4 | M45682 | |
| Coexpression | CUI_TCF21_TARGETS_UP | 5.15e-05 | 37 | 51 | 3 | MM1171 | |
| Coexpression | DESCARTES_ORGANOGENESIS_DEFINITIVE_ERYTHROID_LINEAGE | 9.93e-05 | 46 | 51 | 3 | MM3654 | |
| Coexpression | CASTELLANO_HRAS_AND_NRAS_TARGETS_UP | 1.03e-04 | 8 | 51 | 2 | MM1086 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 3.86e-05 | 165 | 49 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.31e-05 | 183 | 49 | 5 | Arv_SC-HD_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.32e-05 | 194 | 49 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.18e-06 | 159 | 52 | 5 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.45e-06 | 166 | 52 | 5 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 1.54e-06 | 168 | 52 | 5 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 1.73e-06 | 172 | 52 | 5 | 2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.99e-06 | 177 | 52 | 5 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.99e-06 | 177 | 52 | 5 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.99e-06 | 177 | 52 | 5 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-06 | 179 | 52 | 5 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-06 | 179 | 52 | 5 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-06 | 179 | 52 | 5 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-06 | 180 | 52 | 5 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-06 | 184 | 52 | 5 | 15f2c10101ccc8ed059520fc082ee42593dff269 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-06 | 184 | 52 | 5 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-06 | 185 | 52 | 5 | 0fff2608f507e019ebb69c27e58fd5be3b049bef | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-06 | 185 | 52 | 5 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-06 | 190 | 52 | 5 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-06 | 190 | 52 | 5 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-06 | 191 | 52 | 5 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 192 | 52 | 5 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-06 | 194 | 52 | 5 | a4a70369541876e1192df8828b63e3d1746ae3d9 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.20e-06 | 195 | 52 | 5 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-06 | 195 | 52 | 5 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-06 | 195 | 52 | 5 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.20e-06 | 195 | 52 | 5 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.28e-06 | 196 | 52 | 5 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 3.28e-06 | 196 | 52 | 5 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 197 | 52 | 5 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.36e-06 | 197 | 52 | 5 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-06 | 197 | 52 | 5 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.36e-06 | 197 | 52 | 5 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 199 | 52 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.77e-06 | 90 | 52 | 4 | 6adc78899a08d48da8ed4618ecf866c9ed9be059 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.77e-06 | 90 | 52 | 4 | a74f8172780adc1410e36e2718412010ee0ebf1f | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.77e-06 | 90 | 52 | 4 | 909ad62d175b657d8e541b0981ce8fed0ba7ed6c | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.77e-06 | 90 | 52 | 4 | 936c5078677ec934f3049d8aa5a14d930aa2e6dc | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.99e-05 | 137 | 52 | 4 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.29e-05 | 142 | 52 | 4 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 150 | 52 | 4 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-05 | 155 | 52 | 4 | 93bfcf5c12cbb61a1e0444312afd2aa411a8bf50 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.31e-05 | 156 | 52 | 4 | 5d9e1df70f2e9219f6b029be2e39297605d36726 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-05 | 157 | 52 | 4 | 554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-05 | 157 | 52 | 4 | 2cb3deb5313ce734710c601935ca318e4179077e | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-05 | 158 | 52 | 4 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.48e-05 | 158 | 52 | 4 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.48e-05 | 158 | 52 | 4 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.56e-05 | 159 | 52 | 4 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 159 | 52 | 4 | 9f6607e395bcca9cb1c83199bdbbaaa62a93938d | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.56e-05 | 159 | 52 | 4 | 1827493fb464bbddb2ee23f99472cfbcaf57405b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 159 | 52 | 4 | c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7 | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 3.65e-05 | 160 | 52 | 4 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | Mild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass | 3.65e-05 | 160 | 52 | 4 | aa79848913910c01249d6cacf4ed53ec0e4f5c3d | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.83e-05 | 162 | 52 | 4 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.83e-05 | 162 | 52 | 4 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 167 | 52 | 4 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-05 | 167 | 52 | 4 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.31e-05 | 167 | 52 | 4 | afb6d0993f3fd44a295874673055189d514f7b11 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 4.42e-05 | 168 | 52 | 4 | e8bd090de5c9fe286b08a8b314ce12cf988184f0 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.52e-05 | 169 | 52 | 4 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-05 | 169 | 52 | 4 | 0c2384f780ec25710ebb35c0b0df8f4afb53c9b1 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.52e-05 | 169 | 52 | 4 | 6dfc4e3f1ce9d477400a416ba6069b59f14ca1b8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-05 | 169 | 52 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | 4.52e-05 | 169 | 52 | 4 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 4.84e-05 | 172 | 52 | 4 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | 5.18e-05 | 175 | 52 | 4 | 51301f3f44d3e88397f367cedd1e2abaa2be4c6f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.29e-05 | 176 | 52 | 4 | 67d6dc38708692f8c58cea5ed896f10718e9ffa6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.29e-05 | 176 | 52 | 4 | 125be81311f87563ca321472fcce6e0e0ae24c16 | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 5.29e-05 | 176 | 52 | 4 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 5.29e-05 | 176 | 52 | 4 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 177 | 52 | 4 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.41e-05 | 177 | 52 | 4 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-05 | 177 | 52 | 4 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 | |
| ToppCell | Healthy-Plasmablast|Healthy / disease group, cell group and cell class | 5.41e-05 | 177 | 52 | 4 | 4ff75c609ac9edf7a94bda42eb7124c559e8b6aa | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass | 5.41e-05 | 177 | 52 | 4 | 37e03f51925345f5f716ef3abe1d2c4ccf129020 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.65e-05 | 179 | 52 | 4 | fae869fb0a91428481bf8a9c111dcc639e2b4278 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.77e-05 | 180 | 52 | 4 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.90e-05 | 181 | 52 | 4 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.90e-05 | 181 | 52 | 4 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-05 | 181 | 52 | 4 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.90e-05 | 181 | 52 | 4 | f7b08f662eb77ee7a777c6525ddc3195046aaf65 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-05 | 181 | 52 | 4 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-05 | 182 | 52 | 4 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 6.03e-05 | 182 | 52 | 4 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.16e-05 | 183 | 52 | 4 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| ToppCell | Control-Lymphocyte-B-B_memory|Control / Disease, Lineage and Cell Type | 6.16e-05 | 183 | 52 | 4 | 491fa04a1d2caeeec6c6403c9a38b4a1257fc2bc | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.29e-05 | 184 | 52 | 4 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 184 | 52 | 4 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.29e-05 | 184 | 52 | 4 | 14a5288d861260f63fbe0cbea3569cf643e7597e | |
| ToppCell | URO-Myeloid-pDC|URO / Disease, Lineage and Cell Type | 6.29e-05 | 184 | 52 | 4 | 0edb5dd003c2bca0b9e3ec18d03610d68bd52538 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.29e-05 | 184 | 52 | 4 | fc708a5c8a7b19fab973c72dc4383a7d30f8b59a | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 185 | 52 | 4 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 185 | 52 | 4 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 185 | 52 | 4 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.42e-05 | 185 | 52 | 4 | 96423bdcf0e85ca41370f79347d27c22f3de98f5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.42e-05 | 185 | 52 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-05 | 185 | 52 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.42e-05 | 185 | 52 | 4 | 08bc817908076734d66f2805cb954141f2cc5a18 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.42e-05 | 185 | 52 | 4 | 1704a12153a9b107bf03ecccd1a036cf61334d7a | |
| Computational | Neighborhood of ITGAL | 2.25e-05 | 55 | 33 | 4 | GNF2_ITGAL | |
| Computational | Neighborhood of CASP8 | 7.33e-05 | 27 | 33 | 3 | GNF2_CASP8 | |
| Computational | Neighborhood of SNRK | 8.20e-05 | 28 | 33 | 3 | GNF2_SNRK | |
| Computational | Neighborhood of IGFBP1 | 6.89e-04 | 57 | 33 | 3 | CAR_IGFBP1 | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.97e-07 | 200 | 48 | 7 | 4202_UP | |
| Drug | 5194442; Up 200; 20uM; PC3; HT_HG-U133A | 3.42e-06 | 196 | 48 | 6 | 6594_UP | |
| Drug | 2-(oxalylamino)benzoic acid | 3.72e-05 | 89 | 48 | 4 | CID000444764 | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; PC3; HT_HG-U133A | 5.42e-05 | 194 | 48 | 5 | 4657_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A | 5.56e-05 | 195 | 48 | 5 | 4664_DN | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; HL60; HG-U133A | 5.70e-05 | 196 | 48 | 5 | 2033_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 5.70e-05 | 196 | 48 | 5 | 4296_DN | |
| Drug | Pheniramine maleate [132-20-7]; Up 200; 11.2uM; PC3; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 4012_UP | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; HL60; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 2376_DN | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; PC3; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 5114_DN | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 4102_DN | |
| Drug | STOCK1N-28457; Down 200; 20uM; PC3; HT_HG-U133A | 5.98e-05 | 198 | 48 | 5 | 6864_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A | 5.98e-05 | 198 | 48 | 5 | 4194_DN | |
| Drug | N-Ac-Tyr-Val-Ala-Asp-chloromethyl ketone | 5.98e-05 | 36 | 48 | 3 | CID000003722 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 2.37e-06 | 17 | 46 | 3 | DOID:8677 (biomarker_via_orthology) | |
| Disease | c3d:C3 ratio | 2.38e-06 | 2 | 46 | 2 | EFO_0008543 | |
| Disease | calnexin measurement | 7.13e-06 | 3 | 46 | 2 | EFO_0801444 | |
| Disease | complement factor H-related protein 4A measurement | 7.13e-06 | 3 | 46 | 2 | EFO_0600057 | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 7.13e-06 | 3 | 46 | 2 | EFO_0801683 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 1.42e-05 | 4 | 46 | 2 | EFO_0803292 | |
| Disease | kallikrein-5 measurement | 1.42e-05 | 4 | 46 | 2 | EFO_0020515 | |
| Disease | complement C1s subcomponent measurement | 3.55e-05 | 6 | 46 | 2 | EFO_0008091 | |
| Disease | Malignant neoplasm of prostate | 4.41e-05 | 616 | 46 | 7 | C0376358 | |
| Disease | Rectal Neoplasms | 4.97e-05 | 7 | 46 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 4.97e-05 | 7 | 46 | 2 | C0007113 | |
| Disease | Takayasu arteritis | 8.42e-05 | 148 | 46 | 4 | EFO_1001857 | |
| Disease | Atypical hemolytic-uremic syndrome | 8.50e-05 | 9 | 46 | 2 | cv:C2931788 | |
| Disease | beta-mannosidase measurement | 8.50e-05 | 9 | 46 | 2 | EFO_0801421 | |
| Disease | Hemolytic-uremic syndrome | 8.50e-05 | 9 | 46 | 2 | cv:C0019061 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 8.50e-05 | 9 | 46 | 2 | EFO_0801766 | |
| Disease | cystic fibrosis (is_marker_for) | 1.26e-04 | 62 | 46 | 3 | DOID:1485 (is_marker_for) | |
| Disease | hemopexin measurement | 1.30e-04 | 11 | 46 | 2 | EFO_0008149 | |
| Disease | complement factor H-related protein 3 measurement | 1.40e-04 | 169 | 46 | 4 | EFO_0600056 | |
| Disease | Intestinal Neoplasms | 1.55e-04 | 12 | 46 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 1.55e-04 | 12 | 46 | 2 | C0346627 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.83e-04 | 13 | 46 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | anemia (implicated_via_orthology) | 2.46e-04 | 15 | 46 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | tumor necrosis factor beta measurement | 2.46e-04 | 15 | 46 | 2 | EFO_0008308 | |
| Disease | colorectal health | 2.73e-04 | 201 | 46 | 4 | EFO_0008460 | |
| Disease | Benign neoplasm of stomach | 3.19e-04 | 17 | 46 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.19e-04 | 17 | 46 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.19e-04 | 17 | 46 | 2 | C0154060 | |
| Disease | ischemia (biomarker_via_orthology) | 3.58e-04 | 18 | 46 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Carcinoma of bladder | 3.58e-04 | 18 | 46 | 2 | C0699885 | |
| Disease | Prostatic Neoplasms | 3.72e-04 | 616 | 46 | 6 | C0033578 | |
| Disease | urate measurement, bone density | 3.82e-04 | 619 | 46 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | maximal midexpiratory flow rate | 4.44e-04 | 20 | 46 | 2 | EFO_0004313 | |
| Disease | coagulation factor measurement | 4.44e-04 | 20 | 46 | 2 | EFO_0004634 | |
| Disease | Stomach Carcinoma | 4.90e-04 | 21 | 46 | 2 | C0699791 | |
| Disease | chronic hepatitis B virus infection | 6.42e-04 | 24 | 46 | 2 | EFO_0004239 | |
| Disease | Sjogren's syndrome (is_marker_for) | 6.42e-04 | 24 | 46 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Colorectal cancer | 8.14e-04 | 27 | 46 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 8.14e-04 | 27 | 46 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 8.14e-04 | 27 | 46 | 2 | cv:C0009404 | |
| Disease | colorectal cancer (is_implicated_in) | 8.98e-04 | 121 | 46 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | complement factor H-related protein 2 measurement | 9.40e-04 | 29 | 46 | 2 | EFO_0600055 | |
| Disease | Age related macular degeneration | 1.01e-03 | 30 | 46 | 2 | C0242383 | |
| Disease | Complement deficiency disease | 1.22e-03 | 33 | 46 | 2 | C0272242 | |
| Disease | Inflammatory Bowel Diseases | 1.37e-03 | 35 | 46 | 2 | C0021390 | |
| Disease | hair color | 1.39e-03 | 311 | 46 | 4 | EFO_0003924 | |
| Disease | Adenoma, Microcystic | 1.45e-03 | 36 | 46 | 2 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.45e-03 | 36 | 46 | 2 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.45e-03 | 36 | 46 | 2 | C0205646 | |
| Disease | Follicular adenoma | 1.45e-03 | 36 | 46 | 2 | C0205647 | |
| Disease | Papillary adenoma | 1.45e-03 | 36 | 46 | 2 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.45e-03 | 36 | 46 | 2 | C0205651 | |
| Disease | Adenoma | 1.45e-03 | 36 | 46 | 2 | C0001430 | |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 1.45e-03 | 36 | 46 | 2 | DOID:526 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTLYSNFSYGTDEYD | 16 | Q12979 | |
| SGKYLCYFQDGDFYE | 121 | O00478 | |
| SGKYLCYFQDGDFYE | 121 | O00481 | |
| VYSLEAYSCASKYAF | 96 | A0A1B0GW35 | |
| YRYYFKKASDEFACG | 801 | Q9Y2T1 | |
| VGDDFSLYYDSYSVD | 266 | Q96KQ7 | |
| SDSYQYGEEVTYKCF | 946 | P08603 | |
| FSETGFFDYCAVKAY | 401 | Q04671 | |
| ALSYYKSEDETEYGC | 51 | Q9Y5P4 | |
| SAYAYDIEDGKFYCK | 801 | Q7RTP6 | |
| SYEYGASCFYSDKDL | 71 | P31267 | |
| GTCKETFNLYYYESD | 116 | P54764 | |
| KTEDEADYYCQSYDS | 101 | P01721 | |
| SCKETFNLYYYEADF | 106 | P29323 | |
| SYYFDHSSENGYKSC | 821 | Q92824 | |
| TFDGKSYSFDGLCQY | 1286 | Q7Z5P9 | |
| YNFASDCRGSYKEFA | 61 | Q02817 | |
| CEAGDAVYYTASYAK | 1336 | Q9H792 | |
| FSYGEKCLYNVSAYD | 111 | P50549 | |
| AEDEADYYCSLYTSS | 101 | A0A075B6J9 | |
| LCDDYSVADKEYYFD | 56 | Q9BQ31 | |
| EYIATFKGSEYFCYD | 281 | Q9ULB1 | |
| YFTVTCYSGYGDDEK | 91 | Q5F1R6 | |
| SYFCQKAYAYADEDE | 696 | Q02413 | |
| QEACDSYKSGYVYSE | 326 | Q7Z6M3 | |
| SSSYTESYEDGCEDY | 141 | Q9H074 | |
| YIASYGSKKDDYEYC | 26 | P53611 | |
| VSASVYAKYYFDLCA | 171 | P0C7X3 | |
| GEDSGIYSCVYYLDS | 1126 | Q8N6C5 | |
| RGTSDYDDVLSCEYY | 546 | Q9P2N7 | |
| REYDCYGDSYFIDTD | 756 | P49917 | |
| KYSASYDSYSESSGY | 1521 | Q5VT06 | |
| SGKYLCYFQDGDFYE | 121 | P78410 | |
| TLDYECYDGYESSYG | 171 | Q92496 | |
| FESSSYEGYFLACEK | 151 | Q14116 | |
| AEDEADYYCCSYAGS | 101 | P01706 | |
| AEDEADYYCSSYTSS | 101 | P01704 | |
| SQNGYFEDSSYYKCD | 21 | Q8NBS3 | |
| HKFLYTAEYCDSSYF | 386 | P48775 | |
| AEDEADYYCSSYAGS | 101 | P01709 | |
| KFYATSYCTAYGRED | 26 | Q7Z5V6 | |
| DGKLYDAYVSYSDCP | 161 | Q6IA17 | |
| DVGLTCTGYTDYDDY | 866 | A1L4H1 | |
| GYDFTEGSTDKYYCA | 756 | Q4LDE5 | |
| DIAFYYCSDGYSLAD | 2041 | Q4LDE5 | |
| YSEDDESKFCSYGQY | 986 | P25054 | |
| YDYDCGEDFYRSTAP | 11 | P12524 | |
| LSCTYDTSESDYYLF | 41 | P0DTU3 | |
| EFYCDPGYSLTSDYK | 271 | Q5VX71 | |
| CGYDYMEAYDGYDSS | 946 | Q9Y6L7 | |
| CDSDGAQDYYSDYAY | 216 | Q86UK7 | |
| KFKYAQEYDSGTYRC | 146 | Q6P7N7 | |
| LSCTYDTSESDYYLF | 41 | A0JD32 | |
| YKYDAYLCFSSKDFT | 691 | O60602 | |
| SYACYYDEKRSTYLG | 216 | Q99538 |